483 related articles for article (PubMed ID: 1334975)
21. Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin.
Stickings P; Cunningham JM
Cytokine; 2002 Apr; 18(2):81-5. PubMed ID: 12096922
[TBL] [Abstract][Full Text] [Related]
22. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
23. gamma-tocopherol partially protects insulin-secreting cells against functional inhibition by nitric oxide.
Sjöholm A; Berggren PO; Cooney RV
Biochem Biophys Res Commun; 2000 Oct; 277(2):334-40. PubMed ID: 11032727
[TBL] [Abstract][Full Text] [Related]
24. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Corbett JA; Tilton RG; Chang K; Hasan KS; Ido Y; Wang JL; Sweetland MA; Lancaster JR; Williamson JR; McDaniel ML
Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
[TBL] [Abstract][Full Text] [Related]
25. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans].
Chen H; Cai D; Wang M; Liu H
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.
Green IC; Delaney CA; Cunningham JM; Karmiris V; Southern C
Diabetologia; 1993 Jan; 36(1):9-16. PubMed ID: 7679657
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
28. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage.
Scarim AL; Nishimoto SY; Weber SM; Corbett JA
Endocrinology; 2003 Aug; 144(8):3415-22. PubMed ID: 12865320
[TBL] [Abstract][Full Text] [Related]
29. Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
Bolaffi JL; Rodd GG; Wang J; Grodsky GM
Endocrinology; 1994 Feb; 134(2):537-42. PubMed ID: 7507826
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets.
Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML
Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139
[TBL] [Abstract][Full Text] [Related]
31. Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-1 beta (IL-1 beta) without affecting glutamate decarboxylase expression or nitric oxide production.
Eizirik DL; Welsh N; Niemann A; Velloso LA; Malaisse WJ
FEBS Lett; 1994 Jan; 337(3):298-302. PubMed ID: 8293819
[TBL] [Abstract][Full Text] [Related]
32. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function.
Welsh N; Sandler S
Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.
Dunger A; Cunningham JM; Delaney CA; Lowe JE; Green MH; Bone AJ; Green IC
Diabetes; 1996 Feb; 45(2):183-9. PubMed ID: 8549863
[TBL] [Abstract][Full Text] [Related]
34. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
[No Abstract] [Full Text] [Related]
35. Interleukin-1 reduces the glycolytic utilization of glucose by pancreatic islets and reduces glucokinase mRNA content and protein synthesis by a nitric oxide-dependent mechanism.
Ma Z; Landt M; Bohrer A; Ramanadham S; Kipnis DM; Turk J
J Biol Chem; 1997 Jul; 272(28):17827-35. PubMed ID: 9211938
[TBL] [Abstract][Full Text] [Related]
36. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
Corbett JA; McDaniel ML
J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
[TBL] [Abstract][Full Text] [Related]
37. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
Laychock SG
Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells.
Ankarcrona M; Dypbukt JM; Brüne B; Nicotera P
Exp Cell Res; 1994 Jul; 213(1):172-7. PubMed ID: 8020588
[TBL] [Abstract][Full Text] [Related]
39. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
40. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
